2
Publications
29
Citations
2
H-Index
2024
Active since
Peter D. Gabb is an author at Health Economics and Outcomes Research (United Kingdom).
Publications per year
2024–2024
2
2
Dapagliflozin in chronic kidney disease: cost-effectiveness beyond the DAPA-CKD trial
Phil McEwan, Jason A. Davis, Peter D. Gabb et al. · Clinical Kidney Journal · 2024 · 16 citations · Full text
Rows per page
1–2 of 2